Cough And Chest Congestion Dm Solution
NDC 51316-473
Product Information
Cough And Chest Congestion Dm (dextromethorphan hydrobromide, guaifenesin) is a OTC MONOGRAPH DRUG-approved product labeled by Cvs Woonsocket Prescription Center, Incorporated. This medication is typically used as a decreased respiratory secretion viscosity [pe]. It is supplied as a red solution for oral administration. This product entry covers the primary NDC 51316-473 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 51316-473?
What are the uses of this product?
What are Active Ingredients of this product?
- DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL - Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity.
- GUAIFENESIN 200 mg/20mL - An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH)
- DEXTROMETHORPHAN (UNII: 7355X3ROTS) (Active Moiety)
- GUAIFENESIN (UNII: 495W7451VQ)
- GUAIFENESIN (UNII: 495W7451VQ) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- GLYCERIN (UNII: PDC6A3C0OX)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- WATER (UNII: 059QF0KO0R)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)
- SORBITOL SOLUTION (UNII: 8KW3E207O2)
- SUCRALOSE (UNII: 96K6UQ3ZD4)
- XANTHAN GUM (UNII: TTV12P4NEE)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1790650 - dextromethorphan HBr 10 MG / guaiFENesin 100 MG in 10 mL Oral Solution
- RxCUI: 1790650 - dextromethorphan hydrobromide 1 MG/ML / guaifenesin 10 MG/ML Oral Solution
- RxCUI: 1790650 - dextromethorphan HBr 10 MG / guaifenesin 100 MG per 10 ML Oral Solution
- RxCUI: 1790650 - dextromethorphan HBr 20 MG / guaifenesin 200 MG per 20 ML Oral Solution
- RxCUI: 1790650 - dextromethorphan HBr 5 MG / guaifenesin 50 MG per 5 ML Oral Solution
Which are the Pharmacologic Classes of this product?
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
* Please review the full disclaimer at the bottom of this page.